Novo Nordisk A/S (NOV.DE)

EUR 103.14

(-0.33%)

Inventory Summary of Novo Nordisk A/S

  • Novo Nordisk A/S's latest annual inventory in 2023 was 4.26 Billion DKK , up 30.47% from previous year.
  • Novo Nordisk A/S's latest quarterly inventory in 2024 Q1 was 4.49 Billion DKK , up 5.62% from previous quarter.
  • Novo Nordisk A/S reported annual inventory of 3.26 Billion DKK in 2022, up 23.94% from previous year.
  • Novo Nordisk A/S reported annual inventory of 2.63 Billion DKK in 2021, up 5.95% from previous year.
  • Novo Nordisk A/S reported quarterly inventory of 4.49 Billion DKK for 2024 Q1, up 5.62% from previous quarter.
  • Novo Nordisk A/S reported quarterly inventory of 4.26 Billion DKK for 2023 FY, up 30.47% from previous quarter.

Annual Inventory Chart of Novo Nordisk A/S (2023 - 2016)

Historical Annual Inventory of Novo Nordisk A/S (2023 - 2016)

Year Inventory Inventory Growth
2023 4.26 Billion DKK 30.47%
2022 3.26 Billion DKK 23.94%
2021 2.63 Billion DKK 5.95%
2020 2.49 Billion DKK 5.48%
2019 2.36 Billion EUR 7.84%
2018 2.18 Billion EUR 6.02%
2017 2.06 Billion EUR 7.05%
2016 1.92 Billion EUR 0.0%

Peer Inventory Comparison of Novo Nordisk A/S

Name Inventory Inventory Difference
BioNTech SE 357.7 Million EUR -1092.671%
CureVac N.V. 24.82 Million EUR -17087.497%
Biotest Aktiengesellschaft 419.1 Million EUR -917.94%
Biotest Aktiengesellschaft 419.1 Million EUR -917.94%
BRAIN Biotech AG 9.72 Million EUR -43763.722%
Formycon AG 467 Thousand EUR -913430.099%
Heidelberg Pharma AG 10.48 Million EUR -40577.633%
Medigene AG 1.00 EUR -426618556100.0%